Current clinical management of Legionnaires' disease

Expert Review of Anti-Infective Therapy

Volumn 4, Issue 6, 2006, Pages 995-1004

  Garcia Vidal, Carolina ^a   Carratalà, Jordi ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Azithromycin; Community acquired pneumonia; Cooling tower; Fluoroquinolones; Guinea pig model; Legionella pneumophila; Legionnaires' disease; Levofloxacin; Macrolides; Urinary antigen

Indexed keywords

AZITHROMYCIN; BACTERIAL ANTIGEN; CLARITHROMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ANTIGEN DETECTION; ASPIRATION; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; CLINICAL OBSERVATION; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONVALESCENCE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DRUG FATALITY; EPIDEMIC; FATALITY; FEVER; GASTROINTESTINAL DISEASE; HAEMOPHILUS INFLUENZAE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION CONTROL; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LENGTH OF STAY; MONOTHERAPY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; REVIEW; STREPTOCOCCUS PNEUMONIAE; SYMPTOM; THORAX RADIOGRAPHY; TREATMENT OUTCOME; URINALYSIS; WATER QUALITY; WATER SUPPLY; WATER TREATMENT;

ANTI-BACTERIAL AGENTS; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE;

EID: 33845969907     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.4.6.995     Document Type: Review

References (93)

1. Stout JE, Yu VL. Legionellosis. N. Engl. J. Med. 337(10), 682-687 (1997).
2. Pedro-Botet ML, Sabrià M. Legionellosis. Semin. Respir. Crit. Care Med. 26(6), 625-634 (2005).
3. Luttichau HR, Vinther C, Uldum SA, Moller J, Faber M, Jensen JS. An outbreak of Pontiac fever among children following use of a whirlpool. Clin. Infect. Dis. 26(6), 1374-1378 (1998).
4. Jones TF, Benson RF, Brown EW, Rowland JR, Crosier SC, Schaffner W. Epidemiologic investigation of a restaurant associated outbreak of Pontiac fever. Clin. Infect. Dis. 37(10), 1292-1297 (2003).
5. Fraser DW, Tsai TR, Orenstein W et al. Legionnaires' disease: description of an epidemic of pneumonia. N. Engl. J. Med. 297(22), 1189-1197 (1997).
6. McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR. LD: isolation of a bacterium and demonstration of its role in other respiratory disease. N. Engl. J. Med. 297(22), 1197-1203 (1977).
7. Yu VL, Plouffe JF, Pastoris MC et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J. Infect. Dis. 186(1), 127-128 (2002).
8. Fang GD, Yu VL, Vickers RM. Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemiological review. Medicine (Baltimore) 68(2), 116-132 (1989).
9. Muder RR, Yu VL. Infection due to Legionella species other than L. pneumophila. Clin. Infect. Dis. 35(8), 990-998 (2002).
10. Benin AL, Benson RF, Besser RE. Trends in Legionnaires' disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin. Infect. Dis. 35(11), 1039-1046 (2002).
11. Joseph CA; European Working Group for Legionella infections. Legionnaires' disease in Europe 2000-2002. Epidemiol. Infect. 132(3), 417-424 (2004).
12. Edelstein PH. Antimicrobial chemotherapy for LD: time for a change. Ann. Intern. Med. 129(4), 328-330 (1998).
13. Edelstein PH. Antimicrobial chemotherapy for LD: a review. Clin. Infect. Dis. 21 (Suppl.3), S265-S276 (1995).
14. Sopena N, Sabrià M, Pedro-Botet ML et al. Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur. J. Clin. Microbiol. Infect. Dis. 18(12), 852-858 (1999).
15. Rosón B, Carratalà J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin. Infect. Dis. 33(2), 158-165 (2001).
16. Carratalà J, Fernández Sabé N, Ortega L et al. Outpatient care compared with hospitalization for community-acquired pneumonia. A randomized trial in low-risk patients. Ann. Intern. Med. 142(3), 165-172 (2005).
17. Fernández-Sabé N, Carratalà J, Rosón B et al. Community-acquired pneumonia in very elderly patients. Causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 82(3), 159-169 (2003).
18. Rello J, Bodi M, Mariscal D et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 123(1), 174-180 (2003).
19. Vergis EN, Yu VL. New directions for future studies of community-acquired pneumonia: optimizing impact on patient care. Eur. J. Clin. Microbiol. Infect. Dis. 18(12), 847-851 (1999).
20. Marston BJ, Plouffle JF, File TM et al. Incidence of community acquired pnumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch. Intern. Med. 157(15), 1709-1718 (1997).
21. Ricketts KD, Joseph CA, on behalf of the European Working Group for Legionella Infections. LD in Europe 2003-2004. Euro. Surveill. 10(12), 256-259 (2005).
22. Fry AM, Rutman M, Allan T et al. LD outbreak in an automobile engine manufacturing plant. J. Infect. Dis. 187(6), 1015-1018 (2003).
23. Fisman DN, Lim S, Wellenius GA et al. It's not heat, it's the humidity: wet weather increases legionellosis risk in the greater Philadelphia metropolitan area. J. Infect. Dis. 191(12), 2066-2073 (2005).
24. Boshuizen HC, Neppelenbroek SE, van Vliet H et al. Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease. J. Infect. Dis. 184(4), 515-518 (2001).
25. Keller DW, Hajjeh R, DeMaria A et al. Community outbreak of LD: an investigation confirming the potential for cooling towers to transmit Legionella species. Clin. Infect. Dis. 22(2), 257-261 (1996).
26. Nguyen TM, Ilef D, Jarraud S et al. A community-wide outbreak of legionnaires disease linked to industrial cooling towers - how far can contaminated aerosols spread? J. Infect. Dis. 193(1), 102-111 (2006).
27. Sabria M, Alvarez J, Dominguez A et al. A community outbreak of LD: evidence of a cooling tower as a source. Clin. Microbiol. Infect. 12(7), 642-647 (2006).
28. Pedro-Botet ML, Stout JE, Yu VL. LD contracted from patients homes: the coming of the third plague? Eur. J. Clin. Microbiol. Infect. Dis. 21(10), 699-705 (2002).
29. Sabria M, Yu VL. Hospital-acquired legionellosis: solutions for a preventable infection. Lancet Infect. Dis. 2(6), 368-373 (2002).
30. Pedro-Botet ML, Sabria M, Sopena N, Garcia-Nuñez M, Morera J, Reynaga E. Environmental legionellosis and oropharyngeal colonization by Legionella in immunosuppressed patients. Infect. Control Hosp. Epidemiol. 23(5), 279-281 (2002).
31. Carratalà J, Gudiol F, Pallarés R et al. Risk factors for nosocomial Legionella pneumophila pneumonia. Am. J. Respir. Crit. Care Med. 149(3), 625-629 (1994).
32. Roig J, Aguilar X, Ruiz J et al. Comparative study of Legionella pneumophila and other nosocomial-acquired pneumonias. Chest 99(2), 344-350 (1991).
33. Blatt SP, Dolan MJ, Hendrix CW, Melcher GP. LD in human immunodeficiency virus-infected patients: eight cases and review. Clin. Infect. Dis. 18(2), 227-232 (1994).
34. Morley JN, Smith LC, Baltch AL, Smith RP. Recurrent infection due to Legionella pneumophila in a patient with AIDS. Clin. Infect. Dis. 19(6), 1130-1132 (1994).
35. Pedro-Botet ML, Sabria M, Sopena N et al. Legionnaires disease and HIV infection. Chest 124(2), 543-547 (2003).
36. Edelstein PH. LD. Clin. Infect. Dis. 16(6), 741-747 (1993).
37. Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin. Microbiol. Infect. 12(Suppl. 3), 12-24 (2006).
38. Kirby BD, Snyder KM, Meyer RD, Finegold SM. LD: clinical features of 24 cases. Ann. Intern. Med. 89(3), 297-309 (1978).
39. Kirby BD, Snyder KM, Meyer RD, Finegold SM. LD: report of sixty five nosocomially acquired cases and review of the literature. Medicine (Baltimore) 59(3), 188-205 (1980).
40. Brown RB. Legionella pneumonia. The spectrum continues to expand. Chest 125(6), 1979-1980 (2004).
41. Mulazimoglu L, Yu VL. Can Legionnaires' disease be diagnosed by clinical criteria? A critical review. Chest 120(4), 1049-1053 (2001).
42. Tan MJ, Tan JS, Hamor RH et al. The radiologic manifestations of LD. The Ohio Community-Based Pneumonia Study Group. Chest 117(2), 398-403 (2000).
43. Coletta FS, Fein AM. Radiological manifestations of Legionella/ Legionella-like organisms. Semin. Respir. Infect. 13(2), 109-115 (1998).
44. Rosón B, Carratalà J, Fernández-Sabé N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community- acquired pneumonia. Arch. Intern. Med. 164(5), 502-508 (2004).
45. Granados A, Podzamczer D, Gudiol F, Manresa F. Pneumonia due to Legionella pneumophila and pneumococcal pneumonia: similarities and differences on presentation. Eur. Respir. J. 2(2), 130-134 (1989).
46. Sopena N, Sabria-Leal M, Pedro-Botet ML et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 113(5), 1195-1200 (1998).
47. Gupta SK, Imperiale TF, Sarosi GA. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest 120(4), 1064-1071 (2001).
48. Cunha BA. Clinical features of Legionnaires disease. Semin. Respir. Infect. 13(2), 116-127 (1998).
49. Fernández-Sabé N, Rosón B, Carratalà J, Dorca J, Manresa F, Gudiol F. Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. Clin. Infect. Dis. 37(8), 483-489 (2003).
50. Fields BS, Benson RF, Besser RE. Legionella and LD: 25 years of investigation. Clin. Microbiol. Rev. 15(3), 506-526 (2002).
51. Murdoch D. Diagnosis of Legionella infection. Clin. Infect. Dis. 36(1), 64-69 (2003).
52. Ingram JG, Plouffe JF. Danger of sputum purulence screens in culture of Legionella species. J. Clin. Microbiol. 32 (1), 209-210 (1994).
53. Gaia V, Fry NK, Afshar B et al. Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila. J. Clin. Microbiol. 43(5), 2047-2052 (2005).
54. Rihs JD, Yu VL, Zuravleff JJ, Goetz A, Muder RR. Isolation of Legionella pneumophila from blood with the BACTEC system: a prospective study yielding positive results. J. Clin. Microbiol. 22(3), 422-424 (1985).
55. Saravolatz LD, Rusell G, Cvitkovich D. Direct immunofluorescence in the diagnosis of Legionnaires' disease. Chest 79(5), 566-570 (1981).
56. Plouffe JF, File TM Jr, Breiman RF et al. Reevaluation of the definition of LD: use of the urinary antigen assay. Community-Based Pneumonia Incidence Study Group. Clin. Infect. Dis. 20(5), 1286-1291 (1995).
57. Rojas A, Navarro MD, Fornes FE et al. Value of serological testing for diagnosis of legionellosis in outbreak patients. J. Clin. Microbiol. 43(8), 4022-4025 (2005).
58. Dominguez JA, Matas L, Manterola JM et al. Comparison of radioimmunoassay and enzyme immurroassays kits for detection of Legionella pneumophila serogroup 1 antigen in both concentrated and nonconcentrated urine samples. J. Clin. Microbiol. 35(6), 1627-1629 (1997).
59. Dominguez JA, Manterola JM, Blavia R et al. Detection of Legionella pneumophila serogrup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration. J. Clin. Microbiol. 34(9), 2334-2336 (1996).
60. Sopena N, Sabria M, Pedro-Botet ML et al. Factors related to persistance of Legionella urinary antigen excretion in patients with LD. Eur. J. Clin. Microbiol. Infect. Dis. 21(12), 845-848 (2002).
61. Murdoch DR, Walford EJ, Jennings LC et al. Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia. Clin. Infect. Dis. 23(3), 475-480 (1996).
62. Koide M, Saito A. Diagnosis of Legionella pneumophila infection by polymerase chain reaction. Clin. Infect. Dis. 21(1), 199-201 (1995).
63. Cloud JL, Carroll KC, Pixton P, Erali M, Hillyard DR. Detection of Legionella species in respiratory specimens using PCR with sequencing confirmation. J. Clin. Microbiol. 38(5), 1709-1712 (2000).
64. Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur. J. Clin. Microbiol. Infect. Dis. 15(4), 286-290 (1996).
65. Pedro-Botet ML, Yu VL. Legionella: macrolides or quinolones?. Clin. Microbiol. Infect. 12(Suppl.3), 1-6 (2006).
66. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Mosher DM, Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. 37(11), 1405-1433 (2003).
67. Dedicoat M, Venkatesan P. The treatment of Legionnaires' disease. J. Antimicrob. Chemother. 43(6), 747-752 (1999).
68. Stout JE, Sens K, Mietzner S, Obman A, Yu VL. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro roth dilution and intracellular susceptibility testing. Int. J. Antimicrob. Agents 25 (4), 302-307 (2005).
69. Stout JE, Arnold B, Yu VL. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells. Diagn. Microbiol. Infect. Dis. 30(1), 37-43 (1998).
70. Stout JE, Arnold B, Yu VL. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella, species by intracellular susceptibility testing in HL-60 cells. J. Antimicrob. Chemother. 41(2), 289-291 (1998).
71. Baltch AL, Bopp LH, Smith RP, Michelsen PB, Ritz WJ. Antibacterial activities of gemofloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes. J. Antimicrob. Chemother. 56(1), 104-109 (2005).
72. Tano E, Cars O, Löwdin F. Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model. J. Antimicrob. Chemother. 56(1), 240-242 (2005).
73. Smith RP, Baitch AL, Franke M, Hioe W, Ritz W, Michelsen P. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes. J. Antimicrob. Chemother. 40(5), 673-678 (1997).
74. Edelstein PH, Edelstein MAC. In vitro activity of azithromycin against clinical isolates of Legionella species. Antimicrob. Agents Chemother. 35(1), 180-181 (1991).
75. Fitzgeorge RB, Lever S, Baskerville A. A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne LD. J. Antimicrob. Chemother. 31 (Suppl. E), 171-176 (1993).
76. Saito A, Sawatari K, Fukuda Y et al. Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs. Antimicrob Agents Chemother. 28(1), 15-20 (1985).
77. Kitsukawa J, Hara J, Saito A. Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents. J. Antimicrob. Chemother. 27(3), 343-353 (1991).
78. Edelstein PH, Shinzato T, Doyle E, Edelstein MA. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Antimicrob. Agents Chemother. 45(8), 2204-2209 (2001).
79. Plouffe JF, Breiman RF, Fields BS et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. Clin. Infect. Dis. 37(11), 1475-1480 (2003).
80. Yu VL, Greenberg RN, Zadeikis N et al. Levofloxacin efficacy in the treatment of community-acquired legionellosis. Chest 125(6), 2135-2139 (2004).
81. Mykietiuk A, Carratalà J, Fernádez-Sabé N et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin. Infect. Dis. 40(3), 794-799 (2005).
82. Blázquez Garrido MR, Espinosa Parra FJ, Alemany Francés L et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin. Infect. Dis. 40(3), 800-806 (2005).
83. Sabrià M, Pedro-Botet ML, Gámez J et al. Fluoroquinolones vs macrolides in the treatment of Legionnaires disease. Chest 128(9), 1401-1405 (2005).
84. Dournon E, Mayaud CH, Wolff M et al. Comparison of the activity of three antibiotic regimens in severe LD. J. Antimicrob. Chemother. 26(Suppl. B), 129-139 (1990).
85. Roig J, Rello J. LD: a rational approach to therapy. J. Antimicrob. Cbemother. 5(15), 1119-1129 (2003).
86. Martin SJ, Pendland SL, Chen C, Schreckenberger P, Danziger LH. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella. Antimicrob. Agents Chemother. 40(6), 1419-1421 (1996).
87. Den Boer JW, Yzerman EP, Schellekens J et al. A large outbreak of LD at a flower show, the Netherlands, 1999. Emerg. Infect Dis. 8(1), 37-43 (2002).
88. Jernigan DB, Hofmann J, Cetron MS et al. Outbreak of LD among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet 347(9000), 494-499 (1996).
89. Hlady WG, Mullen RC, Mintz CS, Shelton BG, Hopkins RS, Daikos GL. Outbreak of LD linked to a decorative fountain by molecular epidemiology. Am J. Epidemiol. 138(8), 555-562 (1993).
90. Blander SJ, Horwitz MA. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of LD. J. Exp. Med. 169(3), 691-705 (1989).
91. Blander SJ, Horwitz MA. Major cytoplasmic membrane protein of Legionalla pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of LD. J. Clin. Invest. 91(2), 717-723.
92. Weeratna R, Stamler DA, Edelstein PH et al. Human and guinea pig immune response to Legionella pneumophila protein antigens OmpS and Hsp60. Infect. Immun. 62(8), 3454-3462 (1994).
93. Yoon WS, Park SH, Park YK, Park SC, Sin JI, Kim MJ. Comparison of responses elicited by immunization with a Legionella species common lipoprotein delivered as naked DNA or recombinant protein. DNA Cell Biol. 21(2), 99-107 (2002).